[
  {
    "ts": "2025-05-02T11:54:37+00:00",
    "headline": "Should You Hold Bio-Techne Corp. (TECH) For the Long Term?",
    "summary": "Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets started the year with a rally due to optimism about a strong economy and expectations of moderating inflation and lower interest rates. However, concerns over slowing earnings from major Technology companies, geopolitical […]",
    "url": "https://finance.yahoo.com/news/hold-bio-techne-corp-tech-115437047.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "e36d4456-2a08-3943-83f1-f0d3ad4c6604",
      "content": {
        "id": "e36d4456-2a08-3943-83f1-f0d3ad4c6604",
        "contentType": "STORY",
        "title": "Should You Hold Bio-Techne Corp. (TECH) For the Long Term?",
        "description": "",
        "summary": "Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets started the year with a rally due to optimism about a strong economy and expectations of moderating inflation and lower interest rates. However, concerns over slowing earnings from major Technology companies, geopolitical […]",
        "pubDate": "2025-05-02T11:54:37Z",
        "displayTime": "2025-05-02T11:54:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/fb515989613b9407fcd8cf6dd25133e3",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WjAhwdmruNWtOG7DO6GFVQ--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/fb515989613b9407fcd8cf6dd25133e3.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PGVqiPF.kK2SPCpt3fQ8pQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/fb515989613b9407fcd8cf6dd25133e3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hold-bio-techne-corp-tech-115437047.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hold-bio-techne-corp-tech-115437047.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            },
            {
              "symbol": "^RUT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]